Global In-situ Hybridization (ISH) Market 2017-2021
出 版 商：Technavio
出版日期：2017/07/26
頁 數：85頁
文件格式：PDF
價 格：
USD 3,500 (Single-User License)
USD 4,000 (Multi-User License)
USD 5,000 (Global-User License)
USD 4,000 (Multi-User License)
USD 5,000 (Global-User License)
About In-Situ Hybridization (ISH)
ISH is a technique for localizing specific nucleic acid targets within fixed tissues and cells, providing temporal and spatial information about gene expression and genetic loci. While the basic workflow of ISH is similar to that of blot hybridizations, the nucleic acid probe is synthesized, labeled, purified, and annealed with the specific target; the difference is the greater amount of information gained by visualizing the results within the tissue.
Technavio’s analysts forecast the global in-situ hybridization (ISH) market to grow at a CAGR of 6.59% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global in-situ hybridization (ISH) market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of reagents and instruments used to conduct ISH.
The market is divided into the following segments based on geography:
‧ Americas
‧ APAC
‧ EMEA
Technavio's report, Global In-situ Hybridization (ISH) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
‧ Abbott
‧ Agilent Technologies
‧ F. Hoffmann-La Roche
‧ Thermo Fisher Scientific
Other prominent vendors
‧ Advanced Cell Diagnostics
‧ Biocare Medical
‧ Bio SB
‧ BioDot
‧ BioGenex
‧ Cytocell
‧ Exiqon
‧ Genemed Biotechnologies
‧ LGC Biosearch Technologies
‧ Leica Biosystems
‧ Merck
‧ Mirius Bio
‧ PerkinElmer
Market driver
‧ Growing incidence and prevalence of cancer
‧ For a full, detailed list, view our report
Market challenge
‧ Emergence of alternative techniques
‧ For a full, detailed list, view our report
Market trend
‧ Increasing M&A activity in molecular diagnostics market
‧ For a full, detailed list, view our report
Key questions answered in this report
‧ What will the market size be in 2021 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?
‧ What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
ISH is a technique for localizing specific nucleic acid targets within fixed tissues and cells, providing temporal and spatial information about gene expression and genetic loci. While the basic workflow of ISH is similar to that of blot hybridizations, the nucleic acid probe is synthesized, labeled, purified, and annealed with the specific target; the difference is the greater amount of information gained by visualizing the results within the tissue.
Technavio’s analysts forecast the global in-situ hybridization (ISH) market to grow at a CAGR of 6.59% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global in-situ hybridization (ISH) market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of reagents and instruments used to conduct ISH.
The market is divided into the following segments based on geography:
‧ Americas
‧ APAC
‧ EMEA
Technavio's report, Global In-situ Hybridization (ISH) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
‧ Abbott
‧ Agilent Technologies
‧ F. Hoffmann-La Roche
‧ Thermo Fisher Scientific
Other prominent vendors
‧ Advanced Cell Diagnostics
‧ Biocare Medical
‧ Bio SB
‧ BioDot
‧ BioGenex
‧ Cytocell
‧ Exiqon
‧ Genemed Biotechnologies
‧ LGC Biosearch Technologies
‧ Leica Biosystems
‧ Merck
‧ Mirius Bio
‧ PerkinElmer
Market driver
‧ Growing incidence and prevalence of cancer
‧ For a full, detailed list, view our report
Market challenge
‧ Emergence of alternative techniques
‧ For a full, detailed list, view our report
Market trend
‧ Increasing M&A activity in molecular diagnostics market
‧ For a full, detailed list, view our report
Key questions answered in this report
‧ What will the market size be in 2021 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?
‧ What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
‧ Market outline
PART 05: Market landscape
‧ Market size and forecast
‧ Five forces analysis
PART 06: Market segmentation by technology
‧ Market overview
‧ FISH
‧ CISH
PART 07: Market segmentation by end-user
‧ Market overview
‧ Molecular diagnostic laboratories
‧ Pharmaceutical and biotechnology companies
‧ Others
PART 08: Geographical segmentation
‧ Market overview
‧ ISH market in Americas
‧ ISH market in EMEA
‧ ISH market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
‧ Market drivers
‧ Market challenges
PART 11: Market trends
‧ Increasing M&A activity in molecular diagnostics market
‧ National initiatives across the globe spurring molecular research activities
‧ Increasing importance of promotional activities
PART 12: Vendor landscape
‧ Competitive scenario
‧ Investment opportunity
PART 13: Key vendor analysis
‧ Abbott
‧ Agilent Technologies
‧ F. Hoffmann-La Roche
‧ Thermo Fisher Scientific
‧ Other prominent vendors
PART 14: Appendix
‧ List of abbreviations
List of Exhibits
Exhibit 01: Differences between CISH and FISH
Exhibit 02: Snapshot: Overview of global ISH market
Exhibit 03: Global ISH market 2016-2021 ($ millions)
Exhibit 04: Factors affecting global ISH market and their level of impact
Exhibit 05: Five forces analysis
Exhibit 06: Global ISH market by technology 2016 and 2021 (% share)
Exhibit 07: Snapshot: Overview of global ISH market by technology
Exhibit 08: Global FISH market 2016-2021 ($ millions)
Exhibit 09: Global CISH market 2016-2021 ($ millions)
Exhibit 10: Global ISH market by end-user 2016 and 2021 (% share)
Exhibit 11: Snapshot: Overview of global ISH market by end-user
Exhibit 12: Global ISH market by molecular diagnostic laboratories 2016-2021 ($ millions)
Exhibit 13: Global ISH market by pharmaceutical and biotechnology companies 2016-2021 ($ millions)
Exhibit 14: Global ISH market by others 2016-2021 ($ millions)
Exhibit 15: Global ISH market by geography 2016 and 2021 (% share)
Exhibit 16: Snapshot: Overview of global ISH market by geography
Exhibit 17: ISH market in Americas 2016-2021 ($ millions)
Exhibit 18: ISH market in EMEA 2016-2021 ($ millions)
Exhibit 19: ISH market in APAC 2016-2021 ($ millions)
Exhibit 20: List of FDA-approved companion diagnostic tests using ISH
Exhibit 21: Personalized medicine and key statistics from FDA approvals of NMEs
Exhibit 22: Advantages of FISH in detection of foodborne pathogens as compared with conventional methods
Exhibit 23: Head-to-head comparison between traditional FISH and DMI
Exhibit 24: Strategic success factors currently being followed by vendors
Exhibit 25: Investment opportunity mapping
Exhibit 26: Abbott: Profile
Exhibit 27: Abbott: Strength analysis
Exhibit 28: Abbott: Strategy assessment
Exhibit 29: Abbott: Opportunity assessment
Exhibit 30: Agilent Technologies: Profile
Exhibit 31: Agilent Technologies: Strength analysis
Exhibit 32: Agilent Technologies: Strategy assessment
Exhibit 33: Agilent Technologies: Opportunity assessment
Exhibit 34: F. Hoffmann-La Roche: Profile
Exhibit 35: F. Hoffmann-La Roche: Strength analysis
Exhibit 36: F. Hoffmann-La Roche: Strategy assessment
Exhibit 37: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 38: Thermo Fisher Scientific: Profile
Exhibit 39: Thermo Fisher Scientific: Strength analysis
Exhibit 40: Thermo Fisher Scientific: Strategy assessment
Exhibit 41: Thermo Fisher Scientific: Opportunity assessment
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
‧ Market outline
PART 05: Market landscape
‧ Market size and forecast
‧ Five forces analysis
PART 06: Market segmentation by technology
‧ Market overview
‧ FISH
‧ CISH
PART 07: Market segmentation by end-user
‧ Market overview
‧ Molecular diagnostic laboratories
‧ Pharmaceutical and biotechnology companies
‧ Others
PART 08: Geographical segmentation
‧ Market overview
‧ ISH market in Americas
‧ ISH market in EMEA
‧ ISH market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
‧ Market drivers
‧ Market challenges
PART 11: Market trends
‧ Increasing M&A activity in molecular diagnostics market
‧ National initiatives across the globe spurring molecular research activities
‧ Increasing importance of promotional activities
PART 12: Vendor landscape
‧ Competitive scenario
‧ Investment opportunity
PART 13: Key vendor analysis
‧ Abbott
‧ Agilent Technologies
‧ F. Hoffmann-La Roche
‧ Thermo Fisher Scientific
‧ Other prominent vendors
PART 14: Appendix
‧ List of abbreviations
List of Exhibits
Exhibit 01: Differences between CISH and FISH
Exhibit 02: Snapshot: Overview of global ISH market
Exhibit 03: Global ISH market 2016-2021 ($ millions)
Exhibit 04: Factors affecting global ISH market and their level of impact
Exhibit 05: Five forces analysis
Exhibit 06: Global ISH market by technology 2016 and 2021 (% share)
Exhibit 07: Snapshot: Overview of global ISH market by technology
Exhibit 08: Global FISH market 2016-2021 ($ millions)
Exhibit 09: Global CISH market 2016-2021 ($ millions)
Exhibit 10: Global ISH market by end-user 2016 and 2021 (% share)
Exhibit 11: Snapshot: Overview of global ISH market by end-user
Exhibit 12: Global ISH market by molecular diagnostic laboratories 2016-2021 ($ millions)
Exhibit 13: Global ISH market by pharmaceutical and biotechnology companies 2016-2021 ($ millions)
Exhibit 14: Global ISH market by others 2016-2021 ($ millions)
Exhibit 15: Global ISH market by geography 2016 and 2021 (% share)
Exhibit 16: Snapshot: Overview of global ISH market by geography
Exhibit 17: ISH market in Americas 2016-2021 ($ millions)
Exhibit 18: ISH market in EMEA 2016-2021 ($ millions)
Exhibit 19: ISH market in APAC 2016-2021 ($ millions)
Exhibit 20: List of FDA-approved companion diagnostic tests using ISH
Exhibit 21: Personalized medicine and key statistics from FDA approvals of NMEs
Exhibit 22: Advantages of FISH in detection of foodborne pathogens as compared with conventional methods
Exhibit 23: Head-to-head comparison between traditional FISH and DMI
Exhibit 24: Strategic success factors currently being followed by vendors
Exhibit 25: Investment opportunity mapping
Exhibit 26: Abbott: Profile
Exhibit 27: Abbott: Strength analysis
Exhibit 28: Abbott: Strategy assessment
Exhibit 29: Abbott: Opportunity assessment
Exhibit 30: Agilent Technologies: Profile
Exhibit 31: Agilent Technologies: Strength analysis
Exhibit 32: Agilent Technologies: Strategy assessment
Exhibit 33: Agilent Technologies: Opportunity assessment
Exhibit 34: F. Hoffmann-La Roche: Profile
Exhibit 35: F. Hoffmann-La Roche: Strength analysis
Exhibit 36: F. Hoffmann-La Roche: Strategy assessment
Exhibit 37: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 38: Thermo Fisher Scientific: Profile
Exhibit 39: Thermo Fisher Scientific: Strength analysis
Exhibit 40: Thermo Fisher Scientific: Strategy assessment
Exhibit 41: Thermo Fisher Scientific: Opportunity assessment
